We demonstrated that both Fuc-Hpt and Mac-2 bp have potential diagnostic value for evaluating the degree of liver fibrosis in patients with chronic hepatitis C. In addition, these markers might predict the development of HCC. This evidence concerns the gene LGALS3 and hepatocellular carcinoma.